Pentobarbital will minimize the level or influence of elbasvir/grazoprevir by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. The therapeutic outcome of elbasvir/grazoprevir might be diminished if coadministered with sturdy CYP3A inducers which is therefore contraindicated. pentobarbital will reduce the extent or outcome of lapatinib by affecting hepatic/inte... https://daltonsnprk.blogsvirals.com/30367766/an-unbiased-view-of-what-type-of-drug-is-nembutal